Rivastigmine for dementia in patients with Parkinson's disease
Giladi N., Shabtai H., Gurevich T., Benbunan B., Anca M., and Korczyn A. Rivastigmine for dementia in patients with Parkinson's disease. Acta Neurol Scand 108 (2003) 368-373
Preliminary findings: Behavioral worsening on donepezil in patients with frontotemporal dementia
Mendez M., Shapira J., McMurray A., and Licht E. Preliminary findings: Behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15 (2007) 84-87
The efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a systematic review and meta-analysis of controlled trials
Kavirajan H., and Schneider L. The efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a systematic review and meta-analysis of controlled trials. Lancet Neurol 6 (2007) 782-792
Galantamine treatment of vascular dementia: a randomized trial
Auchus A., Brashear H., Salloway S., Korczyn A., De Deyn P., and Grassmann-Mayer C. Galantamine treatment of vascular dementia: a randomized trial. Neurology 69 (2007) 448-458